The longer the drug development process, the more expensive a failure. AstraZeneca expects a server farm to speed up target discovery.
When Astra and Zeneca merged in 1999, Simon Weston got stuck dealing with the extra traffic. Weston manages the company’s Alderley Edge, UK, bioinformatics service for 1,000 scientists who analyze blood cells of patients with oncological and gastrointestinal diseases. Their work entails running a series of bioinformatics applications on public sequence data.